Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study.
- DOI
- 10.1007/s13555-024-01303-z
- Published
- 2024-11-12
- Container
- Dermatol Ther (Heidelb)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s13555-024-01303-z,
title = {Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study.},
author = {Gooderham M and Guttman-Yassky E and Igawa K and Kabashima K and Esfandiari E and Rylands AJ and Williams A and Nixon A and Dent JE and Simpson E.},
year = {2024},
journal = {Dermatol Ther (Heidelb)},
doi = {10.1007/s13555-024-01303-z},
url = {https://doi.org/10.1007/s13555-024-01303-z}
}RIS
TY - JOUR TI - Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study. AU - Gooderham M AU - Guttman-Yassky E AU - Igawa K AU - Kabashima K AU - Esfandiari E AU - Rylands AJ AU - Williams A AU - Nixon A AU - Dent JE AU - Simpson E. PY - 2024 JO - Dermatol Ther (Heidelb) DO - 10.1007/s13555-024-01303-z UR - https://doi.org/10.1007/s13555-024-01303-z ER -
APA
M, G., E, G., K, I., K, K., E, E., AJ, R., A, W., A, N., JE, D., & E., S. (2024). Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study.. Dermatol Ther (Heidelb). https://doi.org/10.1007/s13555-024-01303-z
Source records
- europe-pmc · retrieved 2026-09-26T03:25:22.174Z
- doaj · retrieved 2026-09-26T03:25:22.154Z